Your goals
To develop a treatment
NATIONAL CLINICAL RESEARCH NETWORK FOR THE DESIGN, SPONSORING AND CONDUCT OF PHASE I-IV INTERVENTIONAL AND NON-INTERVENTIONAL CLINICAL TRIALS (AML)
NATIONAL CLINICAL RESEARCH NETWORK TO SUPPORT SPONSORS OF PHASE I TO IV INTERVENTIONAL AND NON-INTERVENTIONAL CLINICAL TRIALS (AML)
NATIONAL CLINICAL RESEARCH NETWORK FOR THE DESIGN, SPONSORING AND CONDUCT OF PHASE I-IV INTERVENTIONAL AND NON-INTERVENTIONAL CLINICAL TRIALS (CLL/WM/AML/MPS)
NATIONAL CLINICAL RESEARCH NETWORK FOR THE DESIGN, SPONSORING AND CONDUCT OF PHASE I-IV INTERVENTIONAL AND NON-INTERVENTIONAL CLINICAL TRIALS - COLLABORATION (CLL/WM/AML/MPS)
NATIONAL CLINICAL RESEARCH NETWORK FOR THE DESIGN, SPONSORING AND CONDUCT OF PHASE II TO IV INTERVENTIONAL AND NON-INTERVENTIONAL CLINICAL TRIALS (ALL)
NATIONAL CLINICAL RESEARCH NETWORK FOR THE DESIGN, SPONSORING AND CONDUCT OF PHASE I TO III INTERVENTIONAL AND NON-INTERVENTIONAL CLINICAL TRIALS (MDS)
NATIONAL CLINICAL RESEARCH NETWORK FOR THE DESIGN AND CONDUCT OF PHASE I-IV INTERVENTIONAL AND NON-INTERVENTIONAL CLINICAL TRIALS IN CHILDHOOD AND ADOLESCENT LEUKEMIA (AML/ALL/MPS/MDS)
COHORT GENOMIC ANNOTATION PLATFORM FOR PHASE I TO III CLINICAL TRIALS (AML/MDS/LEUKEMIA PREDISPOSITION SYNDROMES)
PLATFORM FOR GENOMIC ANNOTATION AND RETROSPECTIVE ANALYSIS OF AML COHORTS
CLINICAL INVESTIGATION CENTER FOR THE SPONSORING AND CONDUCT OF PHASE I TO III INTERVENTIONAL CLINICAL TRIALS (ALL/AML/MPS/MDS)
CLINICAL INVESTIGATION CENTER FOR THE COORDINATION AND CONDUCT OF PHASE I TO III CLINICAL TRIALS IN LEUKEMIA AND RELATED DISEASES (AML, MPS, MDS, ALL)
CLINICAL TRIALS CENTER FOR THE DESIGN, SPONSORING AND CONDUCT OF PHASE I TO IV INTERVENTIONAL AND NON-INTERVENTIONAL CLINICAL TRIALS IN LEUKEMIA (CML, AML, ALL)
METABOLIC, GENOMIC, TRANSCRIPTOMIC AND FUNCTIONAL ANALYSES OF THE LEUKEMIC NICHE FOR PHASE 1 TRIALS (MPN/ALL/AML/MDS)
To deveop an advanced therapy treatment (ATMP)
CLINICAL AND PRECLINICAL EVALUATION OF EFFICACY AND TOXICITY OF CAR-T CELL (ALL/AML) TREATMENTS
PRECLINICAL TESTING OF CAR-T CELLS FOR THE TREATMENT OF T/B ACUTE LYMPHOBLASTIC LEUKEMIA
MANUFACTURING OF ADVANCED THERAPY DRUGS: EARLY CLINICAL TRIALS OF CAR-T CELLS (ALL/AML)
MANUFACTURING OF INNOVATIVE THERAPY DRUGS: PROCESS OPTIMIZATION AND INDUSTRIALIZATION (ALL/AML)
To access patient data
To access biological collections
To explore new scientific insights
ROLE OF PPAR-Y IN HEMATOPOIESIS AND THE BONE MARROW ENVIRONMENT: PRECLINICAL MODELS AND TESTS (MPN)
STUDIES OF THE MECHANISM OF HEMATOPOIETIC STEM CELL TRANSFORMATION IN ACUTE MYELOID LEUKEMIA AND CLONAL SELECTION MODELS
STUDY OF MOLECULAR MECHANISMS REGULATING NORMAL AND MALIGNANT HEMATOPOIESIS (AML)
DEVELOPMENT OF NEW TARGETED THERAPIES FOR ACUTE MYELOID LEUKEMIA